Retinoic acid (RA) induces differentiation of S91 melanoma cells through activation of RA receptor (RAR)g without affecting cell viability. The novel RARg-agonist CD437 (AHPN), however, also induces concomitant apoptosis through an unknown mechanism which was investigated here. By utilizing DNA microarray analysis, five apoptosis-associated, CD437-induced transcripts (CITs) were identified. Interestingly, all CITs are also regulated by p53 in a DNA damage response, and consistent with this interpretation, CD437 was found to cause DNA adduct-formation. However, p53 is not required for CD437-dependent regulation of CITs. Among this set of genes, induction of p21 WAF1/CIP1 is likely to be responsible for early S-phase growth-arrest of CD437-treated cells, whereas ei24 is a critical mediator of CD437-induced apoptosis in S91 cells. These data suggest an RARindependent mechanism in which CD437 causes DNA adduct-formation, resulting in induction of a p53-independent DNA damage response, and subsequent growth-arrest and apoptosis. CD437-mediated DNA adduct-formation may also explain its apoptotic effects in other cell types. Cell Death and Differentiation (2001) 8, 878 ± 886.
Introduction
Retinoic acid (RA) 3 and other retinoids are small molecules derived from retinol (Vitamin A) which guide proper mammalian embryonic development by activating RARs, a class of ligand-dependent transcription factors which regulate gene expression through binding to RA response elements (RAREs).
1,2 RA can also induce growth-arrest and differentiation of a large variety of tumor cells in vitro 3 and mediate similar effects in some neoplastic tissues, 4 which is the rationale behind the use of retinoids as pharmacological agents for differentiation and chemoprevention therapies in certain cancers. 5, 6 In order to understand the molecular basis of the effects of retinoids on the genetic program of tumor cells, we have utilized the S91 murine melanoma cell line as a model system for the etiology of this disease. RA slows replication of these cells by repressing expression of genes involved in cell division and proliferation, which is then subsequently followed by differentiation without affecting cell viability. 7 Although RARs a, b and g, and retinoid X receptors a and b 8 ± 10 are expressed to varying degrees in S91 cells, differentiation appears to be solely mediated by RARg. 11 Interestingly, however, the RARg-specific agonist CD437 (6-(3-(1-adamantyl)-4-hydroxyphenyl)-2-naphthoic acid, or AHPN) not only induces differentiation, but also rapid concomitant apoptosis which can be detected after 8 h of treatment. The latter process is cycloheximide (CHX)-dependent and most likely requires new gene expression. 11 The combined effects of CD437 may, therefore, represent a mixture of RARg-dependent and independent gene expression-modulating activities. Consistent with this interpretation, it was reported that CD437 can induce apoptosis in RA-resistant cells 12 and RAR-antagonists were incapable of blocking CD437-mediated apoptosis. 13 At present, the mechanism behind the differential activities of RA and CD437, in particular as they relate to apoptosis, remain largely unknown. With the possible exception of the cyclin dependent kinase inhibitor (cdkI) p21 WAF1/CIP1 , which appears to be universally induced by CD437, 12,14 ± 19 expression or activity of several other genes or gene products such as c-myc, 20 AP-1, 17, 21 Nur77, 17 GADD45, 12, 22 Cyclin A, 16, 19 Bcl-2, 12, 14, 15, 17, 18 Bcl-X L , 1 2 , 1 5 , 1 7 , 2 3 Bcl-X S , 1 6 Bax, 1 4 , 1 5 , 1 7 , 1 8 Bad, 1 6 p53, 16, 18, 21, 24 E2F-1, 19 and caspases 19, 25, 26 have been variously reported to be either unchanged, down or upregulated, with different kinetics and in a cell typedependent manner in response to CD437. Not surprisingly, it is difficult to discern a putative common CD437-dependent mechanism among these findings. This is an important issue, because dissection of the CD437-dependent signaling cascade could provide new insights into how this, and other novel conformationally-restricted retinoids regulate gene expression and change the fate of tumor cells, and this information may eventually aid in the development of new therapies.
In order to determine the mechanism of CD437-mediated apoptosis we again used the S91 cell system because they are very sensitive to this compound. 11 We have utilized gene expression DNA microarrays to apply a relatively unbiased and systematic genetic screen for transcripts which are specifically induced by CD437 but not by RA, and thus are specifically associated with apoptosis. In experiments desribed here, we identified five CD437-induced transcripts (CITs), four of which had not been previously identified as such. Interestingly, they all belong to a category of p53-regulated cDNAs which are induced after DNA damage and consistent with this interpretation, we subsequently show that CD437, but not non-apoptotic retinoids, induces DNA adduct formation in a relatively cell type independent manner. However, our experiments using p53-depleted S91 cells suggest that there is an alternative, p53-independent regulatory pathway of CIT-regulation. Finally we established a critical physiological role for two CITs in CD437-induced growth-arrest and apoptosis.
Taken together, our results provide evidence for a novel model for the mechanism of the concomitant differentiation and apoptosis-inducing activities of CD437. One activity is that of an RARg-agonist which leads to growth-arrest and differentiation without causing cell death. The newlyidentified pathway is likely to be an RARg-independent DNA adduct-forming activity and, in S91 cells, this results in a p53-independent DNA damage-response. CD437-mediated DNA damage may explain why most cells, irrespective of their sensitivity to RA, are responsive to CD437, and it may also explain the divergent genetic response to CD437.
Results
Identi®cation of CITs associated with apoptosis: evidence for an RAR-independent DNA damage response
To identify CITs which mediate CD437-induced apoptosis in S91 cells, gene expression DNA microarrays were utilized in order to systematically screen for differentially expressed cDNAs between DMSO (control)-treated cells, and cells were treated for 8 h with CD437. This time frame was chosen because CD437-induced apoptosis becomes detectable after 8 h treatment. 11 Five CITs were found to be induced by CD437, but not by RA or the RARa-agonist Am580 and the RARb-agonist CD2314, as shown in a Northern blot analysis Figure 1A , and thus by this criteria CITs are all associated with apoptosis. As an internal control for the quality of the ligands, all compounds were shown to induce RARb expression. 11 One of the CITs, p21 WAF1/CIP1 , was previously shown to be induced by CD437 and thus validates the assay. 12,14 ± 19 The other four CITs had not yet been identified as CD437-responsive transcripts and included: MDM2, an oncogene mainly known for its ability to inhibit p53-activity; 27 TEAP (thymus-expressed acidic protein), an uncharacterized, novel cDNA which has been associated with thymocyte development; 28 cyclin G1, a cyclin with unknown function which is induced after UV-B and ionizing radiation; 29 and finally ei24, a cDNA which is induced in fibroblasts after treatment with etoposide or ionizing radiation; 30 and which recently was shown to have apoptotic activity in these cells. 31 A striking feature of four of five CITs (p21 WAF1/CIP1 , MDM2, cycG1 and ei24) is that they are known to be regulated by p53 in response to DNA damage 27, 29, 30 which may be indicative of a potentially RAR-independent mechanism of CD437-mediated gene regulation. To test this interpretation, we first wanted to establish whether S91 cells have a competent, p53-dependent DNA damage response and whether TEAP also falls into the same category as the other four genes. S91 cells were first stably infected with a retrovirus encoding the human papilloma virus E6 protein, which abrogates p53-function, or with control retrovirus. Control and E6-expressing cells were then treated for 16 h with DMSO (control) or the UVmimetic compound 4NQ, total RNA was isolated and expression of TEAP was compared to that of the wellestablished DNA damage-regulated controls p21
and MDM2 by Northern blot analysis. The results, shown in Figure 1B , demonstrate that S91 cells have a functional, p53-dependent DNA damage response mechanism because 4NQ mediated induction of p21 WAF1/CIP1 and MDM2 which was significantly inhibited in the E6-transfectants. Interestingly, TEAP expression is similarly induced by 4NQ and blocked by depletion of p53, suggesting that TEAP is a novel p53-regulated, DNA damage-response gene.
A potential CD437-mediated DNA damage-response gene expression profile was also observed in the RAresistant, human melanoma cell line A375. 7 Cells were treated for 16 h with DMSO (control), RA or CD437 after which RNA was extracted and expression of p21
and MDM2 was again analyzed by Northern blot analysis. As shown in Figure 1C , both DNA damage-response genes were strongly induced by CD437. This suggests that related, if not fully conserved, mechanism(s) are operative in both murine and human melanoma cells, irrespective of the RAsensitivity of the cells, in agreement with a previous report.
12
CD437 induces DNA adduct-formation in a cell-type independent manner
The previous results raise two important questions: Does CD437 induce DNA damage, and secondly, does it mediate regulation of CITs through p53? To address the first issue, S91 were treated for 8 h with DMSO (control) and CD437, and also with the non-apoptotic retinoids RA and the chemically unrelated RARg-agonist CD666 ((E)-4-(1-Hydroxy-1-(5,6,7,8-
. 32 Chromosomal DNA was extracted and completely digested by nucleases. Nucleotides were labeled with 32 P, resolved by 4-D thin layer chromatography and detected by autoradiography. 33 The results, shown in Figure 2 , reveal the existence of a new adducted nucleotide in samples from CD437-treated cells but it is absent in DNA from cells treated with the other non-apoptotic compounds. The adduct was also detected in 3T3 fibroblasts after CD437-treatment, but not in DMSO (control)-treated cells. These results suggest that CD437 induces DNA adduct-formation in a cell-type independent manner, and provide evidence that the observed DNA damage is linked to the onset of the apoptotic process (3T3 cells also undergo CD437-mediated apoptosis; data not shown).
CD437 regulates expression of CITs in a p53-independent manner
To answer the second question, S91 cells were transiently transfected with a promoter construct containing the p53 response element (p53RE) of MDM2 linked to a Luc reporter gene 34 and then treated for 16 h with DMSO (control), RA or CD437. As a positive control for CD437 agonist-activity, a similar reporter plasmid was transfected which contained the bRARE. 11 The results in Figure 3A show that in contrast to the bRARE, which was strongly activated by both CD437 and RA, a p53-dependent promoter was not activated by CD437 suggesting that CD437-treatment does not result in activation of p53. Two other reporter constructs with p53REs within larger segments of promoter regions of the p21 WAF1/CIP1 and MDM2 genes also failed to show induction (data not shown).
To further address this issue, we again utilized the stably transfected control and p53-deficient (E6-expressing) S91 cells. Cells were treated for 8 h with DMSO (control) or CD437, total RNA was isolated and expression of CITs was analyzed by Northern blot ( Figure 3B ). CD437 still induced expression of all CITs although basal levels of some of the CITs, such as p53-regulated genes p21 WAF1/CIP1 and MDM2 are moderately reduced in the E6-transfectants.
Taken together, these results suggest that CD437 activates an alternative, p53-independent signaling pathway for CIT-regulation in S91 cells.
CD437-mediated induction of p21
WAF1/CIP1 is associated with early S-phase growth-arrest Next, we investigated the physiological consequences of CIT-induction for cell cycle progression and apoptosis. p21 WAF1/CIP1 is a well-characterized cell cycle inhibitor, 35, 36 and induction of this gene can be expected to have a strong effect on the cell cycle. S91 cells were treated with RA or CD437 for various periods of time, and DNA content was determined by FACScan analysis ( Figure 4A ). RA-treatment shifted cells from G 2 /M to G 1 /G 0 , particularly between 8 and 16 h, consistent with previous reports. 7 Extended treatment with RA resulted in a gradual increase of cells in G 1 /G 0 but cell-viability was not affected. In contrast, within 4 h of CD437-treatment the G 2 /M-phase had virtually disappeared and more cells had shifted to G 1 /G 0 . After 8 h, cells appeared to be arrested at the G 1 /S check point. Cell viability was not yet significantly affected by 8 h, but between 8 and 16 h the sub-G 1 DNA content began to increase due to apoptosis, as previously shown by different, apoptosis-specific techniques. 11 It is likely that induction of p21 WAF1/CIP1 is responsible for the early S-phase arrest of CD437-treated cells.
To determine whether expression of other cell cycle genes may be regulated by CD437, additional Western blots were performed because many cell cycle regulators are controlled at the post-transcriptional level. 37 Cells were again treated with DMSO (control), RA or CD437, harvested, whole cell extracts were made and protein expression was analyzed by immunoblotting. As shown in Figure 4B , p21 WAF1/CIP1 was strongly induced in S91 cells by CD437 after 2 h treatment consistent with our FACscan and mRNA expression studies. No evidence for RAdependent regulation of p21 WAF1/CIP1 was observed in these cells, despite a putative RARE in its promoter. 38 Levels of cyclin D, but not those of cyclins A and E were down-regulated after 16 h treatment with CD437 which may reflect the beginning of differentiation. 7, 39 No change in expression levels of CdkI p18 INK4C , Cdk's 2 and 4, and E2F-1 were found (data not shown), indicating that CD437 changes expression of only a specific set of cell cycle proteins.
In addition to this set of effectors, expression levels of a group of proteins known to be involved in apoptotic processes were examined. CD437 did not induce changes in levels of p53, Bax, Bcl-2, Bcl-X L and caused only a very small reduction of caspase-3 substrate poly (ADP ribose) polymerase (PARP). Expression of Bad and Bcl-X S could not be detected (data not shown). These results provide further evidence 11 that the mechanism of CD437-dependent apoptosis in S91 cells is not likely to be mediated by p53, and argue against a critical role for alterations in the Bcl-2/Bax balance, or caspase-3 activation levels. 
ei24 Is a critical mediator of CD437-mediated apoptosis in S91 cells
Recently, ei24 was shown to have pro-apoptotic activity when ectopically expressed in fibroblasts. 31 Therefore, it seemed reasonable to establish a putative role for ei24 in CD437-mediated apoptosis and we tested whether abrogation of ei24 expression could protect cells from the apoptotic activity of CD437. Cells were transfected with two different antisense oligonucleotides (AS1 and AS2, which are complementary to different regions spanning the translational start site of ei24 mRNA) and also with two matched sense control oligonucleotides (S1 and S2). After transfection, cells were treated for 20 h with CD437 and cell viability was determined by Trypan Blue staining. As shown in Figure 5 , CD437 caused substantial cell death in both untransfected and mock transfected cells. However, transfection of AS1 and AS2 suppressed CD437-mediated cell death back to control levels, whereas control oligonucleotides S1 and S2 had no effect. In the absence of a commercially available antibody to native ei24, we were able to show that AS2 reduced expression of a FLAG-tagged transfected ei24 ( Figure 5 , inset). These results establish ei24 as a critical apoptotic mediator of CD437 in S91 cells.
Discussion
RA controls gene expression through activation of RARs. Previously, we showed that RARg in particular is likely to play a critical role in the process of differentiation of S91 melanoma cells. 11 However, experiments with the RARg-agonist CD437 showed that this compound, apart from its`classic' agonist quality of activating RARg-dependent transcriptional regulation, also has concomitant unknown, but likely RARindependent apoptotic activities. Dissection of these two pathways may provide new insights in retinoid-dependent signaling which could also have clinical implications. For instance, CD437 may be efficacious in instances where RA is not exerting any effect; melanoma cells such as A375 are resistant to RA but are still responsive to CD437. A large number of studies have been reported on the activity of CD437 on a variety of different tumor cells, but unfortunately these have failed to reveal a shared mechanism. In this report we have identified a novel pathway which can provide an explanation for these observations. RA and CD437 both act as agonists for RARg which results in slow growth-arrest, likely due to suppression of several critical cell cycle regulators, 11 and which in turn may mark the start of differentiation. The other, concomitant pathway is a DNA adduct-forming activity associated with CD437-dependent apoptosis which likely occurs without involvement of RARg, which is also consistent with our finding that the RARb/g antagonist CD2366 does not block the induction of CITs and apoptosis by CD437 (data not shown). Several lines of evidence suggest that adduct-formation lies at the basis of CD437-mediated apoptosis. First, the adduct appears within 8 h of treatment with CD437, at a point coincident with the onset of apoptosis; 11 secondly, non-apoptotic retinoids RA and CD666 do not cause formation of this adduct, and finally, all CITs are DNA damage-response genes and ei24 is a critical mediator of apoptosis. Although alternative mechanisms cannot be completely ruled out, 40 we believe that our data can be most readily explained by this interpretation. The DNA damage-sensing mechanism in S91 cells then triggers induction of CITs which has dramatic effects on cell physiology. Induction of p21 WAF1/CIP1 is most likely responsible for growth-arrest in early S-phase, but not apoptosis, consistent with a report by Li et al. who showed that p21 WAF1/CIP1 is not required for CD437-mediated apoptosis of lung cancer cells. 17 Elevated levels of ei24 appear to relay a critical apoptotic signal although the mechanism of action of this effector remains to be established. 31 The functional role of the other three CITs in S91 cells is much less clear. For instance, the primary function of MDM2 is to impair p53-activity 27 and induction of MDM2 has been generally linked to protection from, rather than induction of, apoptosis. 41 ± 44 However, our data suggest that, unlike some other cell types, 16, 18, 21 CD437-mediated regulation of CITs is largely p53-independent in S91 cells, and induction of ei24 may bypass this pathway altogether. Alternative, p53-independent mechanisms have already been known to exist for, for instance, induction of p21 WAF1/CIP1 and MDM2. 45 ± 48 The functional significance of increased levels of cyclin G1 and TEAP mRNA in S91 cells also remains to be established.
CD437 caused DNA adduct-formation in neuroectodermal S91 melanoma cells and in mesenchymal 3T3 fibroblasts which indicates that this process can occur in highly divergent cell types. In contrast, the genetic response to this effect appears highly cell type-specific. For instance, in lung cancer cells, AP-1 and NUR77 are critical for CD437-mediated apoptosis 17 and in T cell lymphomas caspase-3 is directly activated by CD437, 26, 49 whereas in S91 cells we were unable to detect induced expression, DNA-binding or transactivational activity by AP-1 (data not shown) and CD437-mediated apoptosis does not appear to be associated with major changes in the Bcl-2/Bax balance and/or caspase-3 activation. Other apoptosis-inducers have been recently identified which appear to act independently of these parameters, but at present it is unknown whether CD437 activates any down-stream mitochondrial effectors. 50 Recently, a report by Marchetti et al. showed that CD437 can disrupt the inner mitochondrial transmembrane potential in myeloma cells resulting in generation of reactive oxygen species 51 but no increase in reactive oxygen species levels could be detected in CD437-treated cells (data not shown). Our data nevertheless suggest that the majority of cell type-specific effects of CD437 reflect both common and differential biological responses to the same CD437-induced DNA adducts. Many of the transcripts previously reported to be induced by CD437 are known to be encoded by DNA damageresponse genes, such as p21 WAF1/CIP1 , AP-1, TP53, and GADD45. 12,14 ± 19,21,22,24 Our novel observations may aid in the development of a specific class of DNA adduct ± and apoptosis-inducing synthetic retinoids for retinoid therapy of neoplastic disease whose activity is independent of RAR signaling. In this respect, it will be interesting to analyze the precise nature of the adduct induced by this novel activity of CD437. Additionally, CD437's p53-mimetic, yet p53-independent activity may also have clinical potential in proliferative disorders where p53-activity is often lost due to genetic mutations.
Materials and Methods
Cell culture S91 murine melanoma cells and Swiss 3T3 fibroblasts were grown in Dulbecco's modified Eagle's medium with 10% (v/v) fetal calf serum and donor calf serum, respectively. A375 human melanoma cells were grown in RPMI medium 1640 with 10% (v/v) fetal calf serum (Life 
FACScan analysis
Cells were grown and treated as indicated. Then cells were harvested, washed with phosphate buffered saline (PBS), and resuspended in 6.5 ml Dulbecco's modified Eagle's medium and fixed with 3.5 ml ethanol. Cells were resuspended in PBS with 8 mg/ml RNAse A and 18 mg/ml propidium iodide (PI), incubated for 30 min and DNA content was determined on a Becton Dickinson FACScan (Bedford, MA, USA).
Plasmids and anti-sense oligonucleotides
Plasmids pRARE 3 -Luc and p53RE-Luc were gifts from Drs. E Linney (Duke University, Durham, NC, USA) and J Xiao (Boston University School of Medicine, Boston, MA, USA). cDNA for TEAP was kindly provided by Dr. Carrier (Centre d'Immunologie INSERM-CNRS de Marseille-Luminy, Marseille, France). The prkMei24 plasmid, which expresses a FLAG epitope-tagged version of murine ei24, was a kind gift from Dr. Zambetti (St. Jude Children's Research Hospital, Memphis, TN, USA). All plasmids were isolated by Clontech plasmid kit (Palo Alto, CA, USA). Two phosophorothioate-modified oligodeoxynucleotides were designed to target ei24 mRNA around the AUG start codon and designated antisense ei24 oligonucleotide 1 (AS1) and antisense ei24 oligonucleotide 2 (AS2) together with two sense control oligonucleotides named S1 and S2, respectively (Life Technologies, Grand Island, NY, USA). AS1: 5'-CCATTCATCATGGAGGGC C, AS2: 5'-CCCCCAAACCATTCATCAT, S1: 5'-GGCCCTCCATGAT-GAATGG, S2: 5'-ATGATGAATGGTTTGGGGG.
DNA adduct assay
S91 and 3T3 cells were plated on 10 cm dishes and treated with the appropriate retinoids at 1 mM for 8 h. Genomic DNA was then isolated (DNeasy Tissue kit, Qiagen, Valencia, CA, USA) and the DNA concentration was measured spectrophotometrically. Detection of 32 P-labeled DNA adducts was detected as described. 33 Briefly, DNA was fully digested by micrococcal endonuclease and spleen exonuclease cleavage (Sigma, St. Louis, MO, USA), after which the digests were labeled with 32 P in the presence of T4 Polynucleotide kinase (New England Biolabs, Beverly, MA, USA). Separation of adduct from unmodified deoxynucleotides was achieved by polyethyleneimine-cellulose thin layer chromatography (JT Baker, Phillipsburg, NJ, USA) in 4-D development followed by autoradiography to detect the DNA adducts.
Transfections
Reporter plasmid transfections and Luciferase (Luc) assays were done as described before, 11 except that appropriate ligands were added 32 h after electroporation for an additional 16 h before harvesting, and normalization of Luc values by protein concentration determination (Pierce, Rockford, IL, USA). The retroviral constructs expressing E6 have been previously described. 52 Permanently transfected cells were selected and maintained in 600 mg/ml G418 (Life Technologies, Grand Island, NY, USA). Lipofectin was used for transfections with antisense or sense oligonucleotides according to the manufacturer's protocol (Life Technologies, Grand Island, NY, USA). After transfection, cells grown in normal medium for 24 h, after which medium was replaced by medium with 1 mM CD437. After 20 h, cells were harvested and cell viability was analyzed by trypan Blue staining and whole cell extracts were made. Transfection of prkMei24 was done by using LipofectAMINE (Life Tech.) according to the manufacturer's recommendations (Life Technologies, Grand Island, NY, USA). Five mg empty vector of ei24 expression vector was used per 6 cm plate. After transfection, cells were grown in normal media and checked for the appearance of apoptotic cells (after 20 h). Both attached and nonadherent cells were collected and analyzed by FACscan.
RNA isolations and northern blot analysis
Total RNA was isolated using Trizol (Life Technologies, Grand Island, NY, USA), poly(A) + RNA by PolyATract system (Promega, Madison, WI, USA). Blotting procedures, preparation of radioactively labeled probes, hybridization/washing conditions and quantitation by PhosphorImager were performed as described, 10 except that ExpressHyb was used (Clontech, Palo Alto, CA, USA).
Western blot analysis and antibodies
Whole cell extracts were made by lysing cells in 50 mM Tris pH 8.0/ 150 mM NaCl/1 mM EDTA/0.1% NP40/50 mM NaF/1 mM NaVO 4 /2 mg/ ml aprotinin and leupeptin/0.2 mM PMSF. Protein concentrations were determined, and equal amounts of cell extract (10 ± 100 mg, depending on the protein of interest) were loaded and separated by 8 ± 12% sodium dodecylsulfate-polyacrylamide gel electrophoresis, blotted onto polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA), sequentially immunoprobed with primary and horseradish peroxidase-coupled secondary antibody, and visualized by ECL Plus (Amersham Pharmacia, Piscataway, NJ, USA) and exposure on BioMax ML film (Kodak, Rochester, NY, USA) according to standard procedures. 10 Antibodies were obtained from Santa Cruz (Santa Cruz, CA, USA), except for cyclin A (Sigma, St. Louis, MO, USA) and E (Oncogene, Cambridge, MA, USA), and FLAG (ZYMEK, San Francisco, CA, USA).
Differential expression cloning and gene expression microarray analysis
Poly(A) + RNA was isolated from cells treated for 8 h with DMSO (control) or 1 mM CD437, and the Clontech PCR-Select cDNA subtraction kit (Palo Alto, CA, USA) was used according to the manufacturer's protocol to obtain CD437-specific cDNA pools. cDNAs were cloned in pGEM-T (Promega, Wisconsin, MI, USA). For the Gene Expression Microarray analysis, poly(A) + RNA from similarly-treated cells was isolated and subsequently analyzed by Genome Systems, St. Louis, MO, USA. The arrays contain about 8700 cDNAs. In all cases, regulation of new cDNAs was verified by Northern blot analysis, and sequenced when required.
